FdaApplication
NDA 021695
Identifiers
- fda_app_no: NDA021695
Properties
| Property | Value |
|---|---|
| applicant_name | LUPIN INC |
| application_type | NDA |
| approval_date | 2004-11-30 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ANTARA (MICRONIZED) | FENOFIBRATE | 130MG | CAPSULE;ORAL |
| ANTARA (MICRONIZED) | FENOFIBRATE | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| ANTARA (MICRONIZED) | FENOFIBRATE | 87MG | CAPSULE;ORAL |
| ANTARA (MICRONIZED) | FENOFIBRATE | 90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| ANTARA (MICRONIZED) | FENOFIBRATE | 43MG | CAPSULE;ORAL |
5 products